Addressing the complexity of the TME with organoids
Immuno-Oncology Insights 2022; 4(1), 115–121
Published: 18 April 2023
The highly complex tumor microenvironment (TME) represents something of a ‘black box’ to the I–O space, and successful translation of therapies for solid tumor applications remains a challenge for the field. In this interview, Etienne De Braekeleer, discusses current progress and future applications of organoids to help recapitulate the TME — along with the importance of building more comprehensive datasets from patient samples.